Insulet Corporation

BEDFORD, MA -- (Marketwired) -- 05/15/13 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the following upcoming investor conferences: The Jefferies 2013 Global Healthcare Conference taking place June 3-6, 2013 at the Grand ... read more

BEDFORD, MA -- (Marketwired) -- 05/06/13 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the first quarter ended March 31, 2013. First Quarter Results First quarter 2013 revenue increased 20% to $57.4 million, compared to $47.8 ... read more

BEDFORD, MA -- (Marketwired) -- 04/23/13 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, announced plans to release its financial results for the first quarter of 2013 on May 6, 2013 after the close of the financial markets. Insulet will ... read more

BEDFORD, MA -- (Marketwire) -- 02/27/13 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the fourth quarter and full year ended December 31, 2012. Fourth Quarter Results Fourth quarter 2012 revenue increased 23% to $57.8 million, ... read more

BEDFORD, MA -- (Marketwire) -- 02/26/13 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the Raymond James 34th Annual Institutional Investors Conference at the JW Marriot Grande Lakes in Orlando. Management ... read more

BEDFORD, MA -- (Marketwire) -- 02/07/13 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, announced plans to release its financial results for the fourth quarter and full year 2012 on February 27, 2013 after the close of the financial ... read more

BEDFORD, MA -- (Marketwire) -- 02/06/13 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the Leerink Swann 2013 Global Healthcare Conference at the Waldorf Astoria in New York City. Management is ... read more

BEDFORD, MA -- (Marketwire) -- 01/23/13 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the appointment of Tracey H. Wielinski as Vice President, Global Regulatory/Clinical Affairs and Quality Assurance. Ms. Wielinski brings two decades of experience in ... read more

BEDFORD, MA -- (Marketwire) -- 01/03/13 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, today announced the sale of $85 million of its common stock pursuant to an underwriting agreement with Canaccord Genuity Inc. The last reported sale price ... read more

BEDFORD, MA -- (Marketwire) -- 01/02/13 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the 31st Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. Management ... read more

BEDFORD, MA -- (Marketwire) -- 12/14/12 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology, today announced that the Company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the next-generation OmniPod® Insulin Management System. The new OmniPod insulin pump is more ... read more

BEDFORD, MA -- (Marketwire) -- 11/28/12 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the following upcoming investor conferences: The Canaccord Genuity Medical Technology & Diagnostics Forum at Le Parker Meridien in New ... read more

BEDFORD, MA -- (Marketwire) -- 11/15/12 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced that it has been ranked 114 on Deloitte's Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences ... read more

BEDFORD, MA -- (Marketwire) -- 11/12/12 -- Insulet Corporation (NASDAQ: PODD) -- Diabetes may be an invisible disease but the support system provided by the Diabetes Online Community (DOC) is growing more apparent every day. The DOC has a new channel for inspiration and encouragement with the launch of ... read more

BEDFORD, MA -- (Marketwire) -- 11/08/12 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the three and nine months ended September 30, 2012. Third quarter 2012 revenue increased 23% to $54.8 million, compared to $44.6 ... read more

BEDFORD, MA -- (Marketwire) -- 11/06/12 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the following upcoming investor conferences: The Lazard 2012 9th Annual Healthcare Conference at the Pierre Hotel in New York ... read more

BEDFORD, MA -- (Marketwire) -- 10/25/12 -- Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, today announced the appointment of John A. Fallon, M.D., F.A.C.P. to the Company's board of directors. A leading health management expert, Dr. Fallon's career includes ... read more

BEDFORD, MA -- (Marketwire) -- 10/22/12 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, announced plans to release its financial results for the third quarter of 2012 on November 8, 2012 after the close of the financial markets. Insulet will ... read more

BEDFORD, MA -- (Marketwire) -- 09/07/12 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the 10th Annual CL King Best Ideas Conference at the Omni Berkshire Place Hotel in New York ... read more

BEDFORD, MA -- (Marketwire) -- 08/08/12 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the three and six months ended June 30, 2012. Second quarter 2012 revenue increased 58% to $51.0 million, compared to $32.2 ... read more